COST EFFECTIVENESS OF AN OUTCOME BASED REIMBURSEMENT MODEL OF PCSK9 INHIBITORS

被引：1
|
作者：
Oren, Ohad
Oren, Michal
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Tel Aviv Univ, Tel Aviv, Israel
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 11期
关键词：
D O I：
10.1016/S0735-1097(18)32294-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A1753
引用
收藏
页码：1753 / 1753
页数：1
相关论文
共 50 条
  • [31] PCSK9 Inhibitors Economics and Policy
    Hlatky, Mark A.
    Kazi, Dhruv S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (21) : 2677 - 2687
  • [32] Clinical Shortcuts: PCSK9 Inhibitors
    Steiner, S.
    Berent, R.
    Derfler, K.
    Sinzinger, H.
    Auer, J.
    JOURNAL FUR KARDIOLOGIE, 2016, 23 (1-2): : 30 - 34
  • [33] Oral PCSK9 Inhibitors: Will They Work?
    Lale Tokgözoğlu
    Angela Pirillo
    Alberico L. Catapano
    Current Atherosclerosis Reports, 2025, 27 (1)
  • [34] Lipid lowering with PCSK9 inhibitors
    Razvan T. Dadu
    Christie M. Ballantyne
    Nature Reviews Cardiology, 2014, 11 : 563 - 575
  • [35] PCSK9 Inhibitors for Statin Intolerance?
    Waters, David D.
    Hsue, Priscilla Y.
    Bangalore, Sripal
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (15): : 1571 - 1572
  • [36] Lipid lowering with PCSK9 inhibitors
    Dadu, Razvan T.
    Ballantyne, Christie M.
    NATURE REVIEWS CARDIOLOGY, 2014, 11 (10) : 563 - 575
  • [37] PCSK9 inhibitors and cardiovascular outcomes
    Steffens, Daniel
    Bramlage, Peter
    Scheeff, Celine
    Kasner, Mario
    Hassanein, Adel
    Friebel, Julian
    Rauch-Kroehnert, Ursula
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (01) : 35 - 47
  • [38] PCSK9 inhibitors for treating hypercholesterolemia
    Pasta, Andrea
    Cremonini, Anna Laura
    Pisciotta, Livia
    Buscaglia, Angelo
    Porto, Italo
    Barra, Fabio
    Ferrero, Simone
    Brunelli, Claudio
    Rosa, Gian Marco
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (03) : 353 - 363
  • [39] Thumbs Up for PCSK9 Inhibitors
    Voelker, Rebecca
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (03): : 217 - 217
  • [40] PCSK9 inhibitors - clinical applications
    Schmidli, Robert
    AUSTRALIAN PRESCRIBER, 2016, 39 (05) : 168 - 170
12345